Department of Neurosurgery, Hospital Clínico Universitario, Servicio Valenciano de Salud, 46010 Valencia, Spain.
Neurosurg Focus. 2010 Feb;28(2):E5. doi: 10.3171/2009.11.FOCUS09234.
Nowadays the role of microsurgical management of intrinsic brain tumors is to maximize the volumetric resection of the tumoral tissue, minimizing the postoperative morbidity. The purpose of this paper was to study the benefits of an original protocol developed for the microsurgical treatment of tumors located in eloquent motor areas where the navigation and electrical stimulation of motor subcortical pathways have been implemented.
A total of 17 patients who underwent resection of cortical or subcortical tumors in motor areas have been included in the series. The preoperative planning for multimodal navigation was done by integrating anatomical studies, motor functional MR (fMR) imaging, and subcortical pathway volumes generated by diffusion tensor (DT) imaging. Intraoperative neuromonitoring included motor mapping by direct cortical stimulation (CS) and subcortical stimulation (sCS), and localization of the central sulcus by using cortical multipolar electrodes and the N20 wave inversion technique. The location of all cortically and subcortically stimulated points with positive motor response was stored in the navigator and correlated with the cortical and subcortical motor functional structures defined preoperatively.
The mean tumoral volumetric resection was 89.1 +/- 14.2% of the preoperative volume, with a total resection (> or = 100%) in 8 patients. Preoperatively a total of 58.8% of the patients had some kind of motor neurological deficit, increasing 24 hours after surgery to 70.6% and decreasing to 47.1% at 1 month later. There was a great correlation between anatomical and functional data, both cortically and subcortically. A total of 52 cortical points submitted to CS had positive motor response, with a positive correlation of 83.7%. Also, a total of 55 subcortical points had positive motor response; in these cases the mean distance from the stimulated point to the subcortical tract was 7.3 +/- 3.1 mm.
The integration of anatomical and functional studies allows a safe functional resection of the brain tumors located in eloquent areas. Multimodal navigation allows integration and correlation among preoperative and intraoperative anatomical and functional data. Cortical motor functional areas are anatomically and functionally located preoperatively thanks to MR and fMR imaging and subcortical motor pathways with DT imaging and tractography. Intraoperative confirmation is done with CS and N20 inversion wave for cortical structures and with sCS for subcortical pathways. With this protocol the authors achieved a good volumetric resection in cortical and subcortical tumors located in eloquent motor areas, with an increase in the incidence of neurological deficits in the immediate postoperative period that significantly decreased 1 month later. Ongoing studies must define the safe limits for functional resection, taking into account the intraoperative brain shift. Finally, it must be demonstrated whether this protocol has any long-term benefit for patients by prolonging the disease-free interval, the time to recurrence, or the survival time.
如今,脑内肿瘤微创手术的作用在于最大限度地切除肿瘤组织,同时将术后发病率降到最低。本文旨在研究一项新方案在位于运动区的肿瘤的显微外科治疗中的益处,该方案整合了导航和皮质下运动通路的电刺激技术。
对 17 例在运动区接受皮质或皮质下肿瘤切除术的患者进行了研究。多模态导航的术前规划是通过整合解剖学研究、运动功能磁共振成像(fMRI)和扩散张量成像(DTI)生成的皮质下通路体积来完成的。术中神经监测包括直接皮质刺激(CS)和皮质下刺激(sCS)的运动映射,以及使用皮质多极电极和 N20 波反转技术定位中央沟。所有皮质和皮质下刺激点的位置都有阳性运动反应,并存储在导航仪中,并与术前定义的皮质和皮质下运动功能结构相关联。
肿瘤的平均体积切除率为术前体积的 89.1%+/-14.2%,8 例患者达到完全切除(>或=100%)。术前共有 58.8%的患者存在某种运动神经功能缺损,术后 24 小时增加到 70.6%,1 个月后下降到 47.1%。解剖学和功能数据之间存在高度相关性,无论是皮质还是皮质下。52 个皮质点接受 CS 刺激后出现阳性运动反应,阳性相关性为 83.7%。此外,55 个皮质下点也出现了阳性运动反应;在这些情况下,刺激点到皮质下束的平均距离为 7.3+/-3.1mm。
解剖学和功能研究的整合可以安全地切除位于功能区的脑肿瘤。多模态导航允许整合和关联术前和术中的解剖学和功能数据。MR 和 fMRI 成像可对皮质运动功能区进行术前解剖学和功能定位,DTI 成像和轨迹追踪可对皮质下运动通路进行定位。术中通过 CS 和 N20 反转波对皮质结构进行确认,通过 sCS 对皮质下通路进行确认。采用该方案,作者在位于运动功能区的皮质和皮质下肿瘤中实现了较好的肿瘤体积切除,术后即刻神经功能缺损发生率增加,但在 1 个月后显著降低。目前的研究必须确定功能切除的安全范围,考虑到术中脑移位。最后,必须证明该方案是否通过延长无病间隔、复发时间或生存时间对患者有长期益处。